Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.

El-Galaly TC, Mylam KJ, Brown P, Specht L, Christiansen I, Munksgaard L, Johnsen HE, Loft A, Bukh A, Iyer V, Nielsen AL, Hutchings M.

Haematologica. 2012 Jun;97(6):931-6. doi: 10.3324/haematol.2011.056010. Epub 2011 Dec 29.

2.

Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.

Dann EJ, Berkahn L, Mashiach T, Frumer M, Agur A, McDiarmid B, Bar-Shalom R, Paltiel O, Goldschmidt N.

Br J Haematol. 2014 Mar;164(5):694-700. doi: 10.1111/bjh.12687. Epub 2013 Dec 7.

PMID:
24313286
3.

Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.

Picardi M, Pugliese N, Cirillo M, Zeppa P, Cozzolino I, Ciancia G, Pettinato G, Salvatore C, Quintarelli C, Pane F.

Radiology. 2014 Jul;272(1):262-74. doi: 10.1148/radiol.14132154. Epub 2014 Apr 6.

PMID:
24708193
4.

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.

Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS.

Cancer. 2014 Jul 15;120(14):2122-9. doi: 10.1002/cncr.28698. Epub 2014 Apr 7.

5.

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.

Devillier R, Coso D, Castagna L, Brenot Rossi I, Anastasia A, Chiti A, Ivanov V, Schiano JM, Santoro A, Chabannon C, Balzarotti M, Blaise D, Bouabdallah R.

Haematologica. 2012 Jul;97(7):1073-9. doi: 10.3324/haematol.2011.056051. Epub 2012 Jan 22.

6.

The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.

Goldschmidt N, Or O, Klein M, Savitsky B, Paltiel O.

Ann Hematol. 2011 Feb;90(2):165-71. doi: 10.1007/s00277-010-1044-8. Epub 2010 Aug 13.

PMID:
20706721
7.

Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center.

El-Galaly T, Prakash V, Christiansen I, Madsen J, Johansen P, Boegsted M, Johnsen HE, Bukh A.

Leuk Lymphoma. 2011 Apr;52(4):597-603. doi: 10.3109/10428194.2010.547642. Epub 2011 Feb 14.

PMID:
21314488
8.

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.

Cheah CY, Dickinson M, Hofman MS, George A, Ritchie DS, Prince HM, Westerman D, Harrison SJ, Burbury K, Wolf M, Januszewicz H, Herbert KE, Carney DA, Tam C, Seymour JF.

Ann Hematol. 2014 Jul;93(7):1193-200. doi: 10.1007/s00277-014-2040-1. Epub 2014 Mar 5.

PMID:
24595733
9.

The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.

Schrepfer T, Haerle SK, Strobel K, Schaefer N, Hälg RA, Huber GF.

Laryngoscope. 2010 May;120(5):937-44. doi: 10.1002/lary.20843.

PMID:
20422687
10.

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.

Cheah CY, Hofman MS, Dickinson M, Wirth A, Westerman D, Harrison SJ, Burbury K, Wolf M, Januszewicz H, Herbert K, Prince HM, Carney DA, Ritchie DS, Hicks RJ, Seymour JF.

Br J Cancer. 2013 Jul 23;109(2):312-7. doi: 10.1038/bjc.2013.338. Epub 2013 Jun 27.

11.

Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.

Lee AI, Zuckerman DS, Van den Abbeele AD, Aquino SL, Crowley D, Toomey C, Lacasce AS, Feng Y, Neuberg DS, Hochberg EP.

Cancer. 2010 Aug 15;116(16):3835-42. doi: 10.1002/cncr.25240.

13.

Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.

Truong Q, Shah N, Knestrick M, Curley B, Hu Y, Craig M, Hamadani M.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):50-5. doi: 10.1016/j.clml.2013.08.009. Epub 2013 Oct 10.

PMID:
24119465
14.

Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma.

Meany HJ, Gidvani VK, Minniti CP.

Pediatr Blood Cancer. 2007 Apr;48(4):399-402.

PMID:
16514616
15.

Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.

Crocchiolo R, Fallanca F, Giovacchini G, Ferreri AJ, Assanelli A, Verona C, Pescarollo A, Bregni M, Ponzoni M, Gianolli L, Fazio F, Ciceri F.

Ann Hematol. 2009 Dec;88(12):1229-36. doi: 10.1007/s00277-009-0752-4. Epub 2009 May 26.

PMID:
19468730
16.

Surveillance imaging in pediatric Hodgkin Lymphoma.

Voss SD.

Curr Hematol Malig Rep. 2013 Sep;8(3):218-25. doi: 10.1007/s11899-013-0168-z. Review.

PMID:
23832681
17.

Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.

Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL.

J Clin Oncol. 2012 Jul 20;30(21):2635-40. doi: 10.1200/JCO.2011.40.7841. Epub 2012 Jun 11.

18.

Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective.

Patel V, Buckstein M, Perini R, Hill-Kayser C, Svoboda J, Plastaras JP.

Leuk Lymphoma. 2013 Oct;54(10):2168-76. doi: 10.3109/10428194.2013.767902. Epub 2013 Feb 12.

PMID:
23331161
19.

18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.

Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R, Carrai V, Nassi L, Bernardi F, Pieroni C, Bosi A.

Oncol Rep. 2005 Nov;14(5):1209-14.

PMID:
16211287
20.

Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?

Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.

Radiology. 2007 Jul;244(1):257-62.

PMID:
17581905
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk